Making a Difference for Cancer Patients with Hybrid and External Control Arms in Clinical Trials
While the traditional approach of studying control and intervention arms concurrently is an effective way to bring new treatment options to patients, the growing availability of high-quality real-world data (RWD) is changing the way we can accelerate results.
Abstracts Accepted for Publication at ASCO 2021
Three abstracts submitted by COTA and various collaborators have been accepted for publication at this year’s meeting. These abstracts demonstrate COTA’s commitment to working with all stakeholders – across healthcare – to bring clarity to cancer care with real-world data.
Working Together to Improve Outcomes: Applying Lessons from Oncology Collaborations to the COVID-19 Pandemic
Leveraging RWD to gain insight into cancer health disparities affecting underserved populations is key to ensuring equitable access, care, and outcomes for all patients.
Miruna Sasu, Ph.D, MBA — Former Head of Johnson & Johnson’s Clinical Trial Feasibility and Advanced Analytics Team — Joins COTA To Drive Clarity in Cancer Care
In her new role as Chief of Life Science Strategy, Miruna will play a critical role in setting the strategy and executing the solutions delivery to meet critical needs in partnership with life science companies to drive efficient and optimal drug development.
COTA Adds New Life Sciences Leadership to Support Growth in Demand for Oncology Real-World Data
To support growing demand for oncology real-world data, COTA is honored to announce a new addition to the team – Paige Whitney. Paige will serve as Vice President of Life Sciences at COTA.
COTA, Inc. and Kite Collaborate To Expand the Use of Real-World Data To Drive Faster, Effective Treatments for Cancers
COTA’s Real-World Data Will Complement Single-Arm Clinical Trials to Accelerate Cancer Research Benefiting Patients
Real-World Data and its Role in Addressing Cancer Health Disparities
Leveraging RWD to gain insight into cancer health disparities affecting underserved populations is key to ensuring equitable access, care, and outcomes for all patients.
Celebrating Black History Month by Supporting Equity in Clinical Trials
We work with large, de-identified data sets extracted and curated from the universe of electronic health records, claims systems, and myriad other sources. And yet, we are always brought back to the fact that amidst the data are the stories of people’s lives and their journeys of care.
COTA Expands Life Sciences Team By Bringing On Key Hire, Shariq Alavi
In our ongoing mission to bring clarity to cancer care, COTA is proud to share a new addition to our growing team — Shariq Alavi. He joins COTA as a new Vice President of Life Sciences.
World Cancer Day: Overcoming the Lack of Data in the Fight Against Pancreatic Cancer
While we have made significant advances in recent years, we are far from providing doctors and patients with the real-world data they need to consistently make treatment decisions that result in the best outcomes, and we must do better.